Medication Safety Lab Interpretation 2026 Update Patient-Friendly For heart failure, digoxin levels are usually targeted around 0.5–0.9 ng/mL; for atrial fibrillation, current US guidance recommends below 1.2 ng/mL when levels are measured. Samples generally need at least 6–8 hours after a dose. Toxicity can occur within the laboratory interval, especially with kidney impairment, low potassium […]
Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a strong interest in AI-supported interpretation of blood test results, he works to connect new technology with everyday clinical practice. His areas of interest include biomarker analysis, clinical decision support research and population-specific reference range optimization. As CMO, he contributes clinical input to the platform's internal benchmarking and provides clinical oversight for the medical quality of Kantesti's educational reports.
Medication Monitoring Lab Interpretation 2026 Update Patient-Friendly For epilepsy, many laboratories use 3–15 mg/L as a reference interval; bipolar disorder has no established concentration target. Interpret the result alongside dose timing, symptoms, and interacting medicines—not as an instruction to change your dose. 📖 ~12 minutes 📅 October 8, 2026 📝 Published: October 8, 2026 🩺 […]
Autoimmune Diabetes Lab Interpretation 2026 Update Patient-Friendly A positive result can support pancreatic autoimmunity, help investigate a specific neurologic syndrome, or be incidental. The deciding clues are the clinical picture, laboratory method, units, and supporting tests—not the positive flag alone. 📖 ~12 minutes 📅 October 8, 2026 📝 Published: October 8, 2026 🩺 Medically Reviewed: […]
Hematology Lab Interpretation 2026 Update Patient-Friendly ADAMTS13 activity below 10% strongly supports TTP when low platelets and red-cell destruction occur together, but an isolated result does not prove an acute episode. Suspected TTP needs emergency assessment and treatment decisions without waiting for the laboratory result. 📖 ~12 minutes 📅 October 8, 2026 📝 Published: October […]
Chemotherapy Safety Lab Interpretation 2026 Update Patient-Friendly DPYD testing identifies inherited variants that can make fluorouracil or capecitabine dangerously difficult to clear. Results help clinicians choose treatment and starting doses, but a negative genetic screen does not guarantee safety. 📖 ~12 minutes 📅 October 7, 2026 📝 Published: October 7, 2026 🩺 Medically Reviewed: October […]
Medication Monitoring Lab Interpretation 2026 Update Patient-Friendly A result inside the laboratory range is not a safety certificate. The last dose, recent treatment changes and accompanying symptoms can completely change its meaning. 📖 ~12 minutes 📅 October 7, 2026 📝 Published: October 7, 2026 🩺 Medically Reviewed: October 7, 2026 ✅ Evidence-Based This guide was […]
Transplant Medication Safety Lab Interpretation 2026 Update Patient-Friendly A tacrolimus trough level measures the drug in whole blood immediately before your next scheduled dose—usually 12 hours after twice-daily treatment or 24 hours after once-daily treatment. Targets depend on your formulation, transplanted organ and time since transplant; mistimed samples can mislead, and dose changes must come […]
Infectious Diseases Lab Interpretation 2026 Update Patient-Friendly A swollen lymph node and a positive Bartonella antibody result can fit cat scratch disease—but neither establishes the diagnosis alone. Timing, the laboratory method, and the specimen chosen for PCR can change the next step. 📖 ~12 minutes 📅 October 7, 2026 📝 Published: October 7, 2026 🩺 […]
Medication Monitoring Lab Interpretation 2026 Update Patient-Friendly A result inside the laboratory range can still miss excessive active drug. Sampling time, treatment purpose, albumin, and symptoms determine what happens next. 📖 ~12 minutes 📅 October 7, 2026 📝 Published: October 7, 2026 🩺 Medically Reviewed: October 7, 2026 ✅ Evidence-Based This guide was written under […]
CMV Antibodies Lab Interpretation 2026 Update Patient-Friendly CMV IgG positive IgM negative usually suggests previous cytomegalovirus exposure rather than a recent first infection. It does not prove that the virus is inactive, guarantee immunity, or exclude a pregnancy-related concern. 📖 ~12 minutes 📅 October 6, 2026 📝 Published: October 6, 2026 🩺 Medically Reviewed: October […]